Iris Pharma, an ophthalmic preclinical and clinical CRO, and RxGen, a specialty preclinical CRO focused on the development and application of translational research models, have established a strategic alliance to offer fully integrated “bench-to-bedside” ophthalmology research services to the global pharmaceutical and biotechnology industries. Iris Pharma will offer immediate access to RxGen’s nonhuman primate ophthalmic research models and related preclinical in vivo services, via a flexible e...